SCHEMBL7519481

SCHEMBL7519481

O=CCCc1cc(Cl)ccc1O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 5/20 0.57
HIF1A Q16665 4/20 0.57
HPGD P15428 4/20 0.57
MEN1 O00255 3/20 0.57
CYP3A4 P08684 3/20 0.57
KMT2A Q03164 3/20 0.57
ALOX12 P18054 2/20 0.57
SMN1; SMN2 Q16637 2/20 0.57
HSP90AA1 P07900 2/20 0.57
HTT P42858 2/20 0.57
SLC22A1 O15245 1/20 0.57
USP2 O75604 1/20 0.57
LMNA P02545 1/20 0.57
MAPT P10636 1/20 0.57
HSPD1 P10809 1/20 0.57
HSPA5 P11021 1/20 0.57
IDO1 P14902 1/20 0.57
CASP1 P29466 1/20 0.57
BLM P54132 1/20 0.57
HSPE1 P61604 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2597823 0.81 HIF1A (0.61) ALOX15HIF1AHPGDMEN1CYP3A4
SCHEMBL27860623 0.81 TDP1 (0.41) ALOX15HIF1AHPGDMEN1CYP3A4
SCHEMBL28657780 0.78 CA3 (0.38) HIF1AHTTLMNAMAPTCA9
SCHEMBL26620876 0.78 ERN1 (0.48) ALOX15HIF1AHPGDCYP3A4KMT2A
SCHEMBL25192903 0.78 NOS3 (0.37) ALOX15HIF1AHPGDMEN1CYP3A4
SCHEMBL23458349 0.78 AMY1A (0.50) ALOX15HPGDMEN1KMT2AALOX12
SCHEMBL7550128 0.78 CYP3A4 (0.39) ALOX15HIF1AHPGDMEN1CYP3A4
SCHEMBL585624 0.77 IDO1 (0.50) HPGDCYP3A4HTTIDO1CYP2C9
SCHEMBL2982937 0.76 ALOX15 (0.65) ALOX15HIF1AHPGDMEN1CYP3A4
SCHEMBL1418003 0.76 HIF1A (0.59) ALOX15HIF1AHPGDMEN1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10179781-B2 Sodium channel modulators for the treatment of pain CHROMOCELL CORPORATION 2019-01-15 US disclosed
EP-0743311-B1 FLAVANONOL DERIVATIVES AND HAIR NOURISHMENT AND GROWTH STIMULANT COMPOSITION CONTAINING THE SAME KAO CORP (JP) 2002-02-13 EP disclosed
US-5876703-A CELL DIFFERENTIATION OF HAIR MATRIX CELLS KAO CORPORATION (JP) 1999-03-02 US disclosed
US-5702691-A Flavanonol derivatives and hair-nourishing, hair growing compositions containing the derivatives KAO CORPORATION (JP) 1997-12-30 US disclosed
EP-0743311-A1 FLAVANONOL DERIVATIVES AND HAIR NOURISHMENT AND GROWTH STIMULANT COMPOSITION CONTAINING THE SAME Kao Corporation (JP) 1996-11-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10179781-B2 Sodium channel modulators for the treatment of pain SCN7A, SCN10A, SCN2A ALOX15 1449/4885HIF1A 1874/4885HPGD 767/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.